Shares of National Research Corporation (NRC) , doing business as NRC Health, have surged 12.3% since the company reported earnings for the quarter ended Sept. 30, 2025, outperforming the S&P 500 index’s 1.5% growth over the same period. Over the past month, NRC stock has risen 4.8%, again outpacing the S&P 500’s 3% advance, signaling growing investor confidence in the company’s recent performance and strategic direction.For the third quarter of 2025, NRC Health reported adjusted net income of 23 cents per ...